A1chieve Program in Russian Federation: a multicenter prospective observational study of insulin analogue treatment efficiency and safety in daily management of patients with type 2 diabetes mellitus, who startand intensify insulin treatment having never received it before
Abstract
References
1. International Diabetes Federation Atlas 5th edition; 2011.
2. Алгоритмы специализированной медицинской помощи больным сахарным диабетом (5-й выпуск). Под ред. И.И. Дедова и М.В. Шестаковой. 2011. 116 С.
3. Сунцов ЮИ. Эпидемиология сахарного диабета и прогноз его распространенности в Российской Федерации. Сахарный диабет. 2011;(1):15-19.
4. UK Prospective Diabetes Study (UKPDS) Group. UKPDS Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998 Sep 12;352(9131):837-853.
5. Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B; American Diabetes Association; European Association for the Study of Diabetes. Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2009 Jan; 32 (1): 193-203.
6. American Diabetes Association. Standarts of medical care in Diabetes - 2011. Diabetes Care. 2011; 34 (1): 11-61.
7. Дедов ИИ, Шестакова МВ, Аметов АС, Анциферов МБ, Галстян ГР, Майоров АЮ, Мкртумян АМ, Петунина НА, Сухарева ОЮ. Консенсус совета экспертов Российской ас- социации эндокринологов по инициации и интенсификации сахароснижающей терапии сахарного диабета 2 типа. Са- харный диабет. 2011; (4): 6-18.
8. International Diabetes Federation. Global Guideline for Type 2 diabetes; 2005.
9. Riedel AA, Heien H, Wogen J, Plauschinat CA. Loss of glycemic control in patients with type 2 diabetes mellitus who were receiving initial metformin, sulfonylurea, or thiazolidinedione monotherapy. Pharmacotherapy. 2007 Aug;27(8):1102-1110.
10. Shah BR, Hux JE, Laupacis A, Zinman B, van Walraven C. Clinical inertia in response to inadequate glycemic control: do specialists differ from primary care physicians? Diabetes Care. 2005 Mar;28(3):600-606.
Review
For citations:
Shestakova M.V. A1chieve Program in Russian Federation: a multicenter prospective observational study of insulin analogue treatment efficiency and safety in daily management of patients with type 2 diabetes mellitus, who startand intensify insulin treatment having never received it before. Diabetes mellitus. 2012;15(1):63-70. (In Russ.)